BRNS
Price
$0.74
Change
+$0.02 (+2.78%)
Updated
Dec 3 closing price
Capitalization
30.21M
106 days until earnings call
Intraday BUY SELL Signals
TARA
Price
$6.79
Change
+$0.57 (+9.16%)
Updated
Dec 3, 04:59 PM (EDT)
Capitalization
260.08M
97 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BRNS vs TARA

Header iconBRNS vs TARA Comparison
Open Charts BRNS vs TARABanner chart's image
Barinthus Biotherapeutics
Price$0.74
Change+$0.02 (+2.78%)
Volume$24.93K
Capitalization30.21M
Protara Therapeutics
Price$6.79
Change+$0.57 (+9.16%)
Volume$33.04K
Capitalization260.08M
BRNS vs TARA Comparison Chart in %
BRNS
Daily Signal:
Gain/Loss:
TARA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
BRNS vs. TARA commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRNS is a Hold and TARA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 04, 2025
Stock price -- (BRNS: $0.70 vs. TARA: $6.22)
Brand notoriety: BRNS and TARA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BRNS: 23% vs. TARA: 80%
Market capitalization -- BRNS: $31.23M vs. TARA: $260.08M
BRNS [@Biotechnology] is valued at $31.23M. TARA’s [@Biotechnology] market capitalization is $260.08M. The market cap for tickers in the [@Biotechnology] industry ranges from $107.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BRNS’s FA Score shows that 1 FA rating(s) are green whileTARA’s FA Score has 1 green FA rating(s).

  • BRNS’s FA Score: 1 green, 4 red.
  • TARA’s FA Score: 1 green, 4 red.
According to our system of comparison, TARA is a better buy in the long-term than BRNS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BRNS’s TA Score shows that 6 TA indicator(s) are bullish while TARA’s TA Score has 4 bullish TA indicator(s).

  • BRNS’s TA Score: 6 bullish, 4 bearish.
  • TARA’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, BRNS is a better buy in the short-term than TARA.

Price Growth

BRNS (@Biotechnology) experienced а -1.45% price change this week, while TARA (@Biotechnology) price change was -17.79% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.32%. For the same industry, the average monthly price growth was +1.23%, and the average quarterly price growth was +54.93%.

Reported Earning Dates

BRNS is expected to report earnings on Mar 20, 2026.

TARA is expected to report earnings on Mar 11, 2026.

Industries' Descriptions

@Biotechnology (+0.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TARA($260M) has a higher market cap than BRNS($30.2M). TARA YTD gains are higher at: 17.708 vs. BRNS (-41.995). TARA has higher annual earnings (EBITDA): -57.01M vs. BRNS (-62.56M). TARA has more cash in the bank: 122M vs. BRNS (86.3M). TARA has less debt than BRNS: TARA (3.95M) vs BRNS (12M). BRNS has higher revenues than TARA: BRNS (15M) vs TARA (0).
BRNSTARABRNS / TARA
Capitalization30.2M260M12%
EBITDA-62.56M-57.01M110%
Gain YTD-41.99517.708-237%
P/E RatioN/AN/A-
Revenue15M0-
Total Cash86.3M122M71%
Total Debt12M3.95M304%
FUNDAMENTALS RATINGS
TARA: Fundamental Ratings
TARA
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
20
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BRNSTARA
RSI
ODDS (%)
Bullish Trend 6 days ago
75%
Bearish Trend 6 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 6 days ago
80%
Bearish Trend 6 days ago
90%
Momentum
ODDS (%)
Bullish Trend 6 days ago
78%
Bullish Trend 6 days ago
75%
MACD
ODDS (%)
Bullish Trend 6 days ago
83%
Bullish Trend 6 days ago
74%
TrendWeek
ODDS (%)
Bullish Trend 6 days ago
78%
Bullish Trend 6 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 6 days ago
87%
Bullish Trend 6 days ago
81%
Advances
ODDS (%)
Bullish Trend 6 days ago
79%
Bullish Trend 9 days ago
82%
Declines
ODDS (%)
Bearish Trend 16 days ago
87%
Bearish Trend 6 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 6 days ago
82%
Bearish Trend 6 days ago
90%
Aroon
ODDS (%)
Bearish Trend 6 days ago
85%
Bearish Trend 6 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
BRNS
Daily Signal:
Gain/Loss:
TARA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LOVFF1.18N/A
N/A
Cannara Biotech Inc.
GLABF0.17N/A
N/A
GEMINA LABORATORIES LTD.
IFNNF41.22N/A
N/A
Infineon Technologies AG
TRRSF28.97N/A
N/A
Trisura Group Ltd
YAMHF7.16N/A
N/A
Yamaha Motor Co., Ltd.

BRNS and

Correlation & Price change

A.I.dvisor indicates that over the last year, BRNS has been loosely correlated with SLNO. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if BRNS jumps, then SLNO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BRNS
1D Price
Change %
BRNS100%
-8.38%
SLNO - BRNS
56%
Loosely correlated
-1.86%
NGNE - BRNS
51%
Loosely correlated
-6.01%
NEUP - BRNS
50%
Loosely correlated
-0.23%
TARA - BRNS
35%
Loosely correlated
-7.79%
BGMS - BRNS
31%
Poorly correlated
-10.84%
More

TARA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TARA has been loosely correlated with ITRM. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if TARA jumps, then ITRM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TARA
1D Price
Change %
TARA100%
-7.79%
ITRM - TARA
35%
Loosely correlated
-7.10%
BRNS - TARA
34%
Loosely correlated
-8.38%
CAMP - TARA
34%
Loosely correlated
+2.25%
SRRK - TARA
33%
Loosely correlated
-2.12%
CRVS - TARA
31%
Poorly correlated
-5.29%
More